Sfmg, LLC Alaunos Therapeutics, Inc. Transaction History

Sfmg, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$2.63 - $3.67 $164,198 - $229,129	-62,433 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$3.02 - $4.94 $3,020 - $4,940	-1,000 Reduced 1.58%	62,433 $189,000
Q1 2018 May 10, 2018	BUY	$3.46 - $5.14 $3,460 - $5,140	1,000 Added 1.6%	63,433 $249,000
Q3 2017 Nov 07, 2017	BUY	$4.99 - $6.57 $311,540 - $410,184	62,433	62,433 $383,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

Stay updated on Sfmg, LLC with notifications on news.